Literature DB >> 23825910

Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection.

Guodong Wang1, Aiwen Wu, Xiaojing Cheng, Jiafu Ji.   

Abstract

OBJECTIVE: To clarify the important clinicopathological factors affecting the early recurrence of adenocarcinoma of esophagogastric junction (AEG).
METHODS: We retrospectively reviewed the clinical data of 147 AEG patients who underwent R0 resection during the period from December 1995 to December 2007. Risk factors asssociated with the early recurrence were analyzed by χ(2) test and logistic regression test.
RESULTS: The mean time to tumor recurrence was 16.3 months after R0 resection, and the 1-year recurrence rate was 48.3%. Univariate analysis showed that the histological grade (poorly and moderately differentiated), number of positive lymph nodes, and vascular invasion were significantly related with the early recurrence (P<0.05). Logistic multivariate regression analysis showed that only histological grade and vascular invasion were independently related with early tumor recurrence (P<0.05).
CONCLUSIONS: Histological grade and vascular invasion are independent factors for predicting the early tumor recurrence after R0 resection for AEG.

Entities:  

Keywords:  Adenocarcinoma of esophagogastric junction (AEG); risk factor; tumor recurrence

Year:  2013        PMID: 23825910      PMCID: PMC3696703          DOI: 10.3978/j.issn.1000-9604.2013.06.11

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  16 in total

1.  Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma.

Authors:  Joel E Tepper; Bert O'Neil
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544

2.  Skin metastases from esophageal and esophagogastric junction cancer.

Authors:  Fernando Am Herbella; Marco G Patti; Guilherme F Takassi
Journal:  J Gastrointest Oncol       Date:  2011-06

3.  Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  Hiroaki Saito; Youji Fukumoto; Tomohiro Osaki; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

4.  Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Marcus Feith; Karen Becker; J Rüdiger Siewert
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

5.  The recurrence pattern of esophageal carcinoma after transhiatal resection.

Authors:  J B Hulscher; J W van Sandick; J G Tijssen; H Obertop; J J van Lanschot
Journal:  J Am Coll Surg       Date:  2000-08       Impact factor: 6.113

6.  Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.

Authors:  T W Rice; G Zuccaro; D J Adelstein; L A Rybicki; E H Blackstone; J R Goldblum
Journal:  Ann Thorac Surg       Date:  1998-03       Impact factor: 4.330

7.  Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.

Authors:  Michael Stahl; Hansjochen Wilke; Martin Stuschke; Martin K Walz; Ulrich Fink; Michael Molls; J Rüdiger Siewert; Michael Schroeder; Hans-Bruno Makoski; Ulrich Schmidt; Siegfried Seeber; Udo Vanhoefer
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-05       Impact factor: 4.553

8.  Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study.

Authors:  Xiao-Dong Zhang; Yong-Qian Shu; Jun Liang; Feng-Chun Zhang; Xue-Zhen Ma; Jian-Jin Huang; Li Chen; Gen-Ming Shi; Wei-Guo Cao; Cheng-Ye Guo; Lin Shen; Mao-Lin Jin
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

9.  Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification.

Authors:  Toni Lerut; Johnny Moons; Willy Coosemans; Dirk Van Raemdonck; Paul De Leyn; Herbert Decaluwé; Georges Decker; Philippe Nafteux
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

10.  Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  S Ohno; S Tomisaki; H Oiwa; Y Sakaguchi; Y Ichiyoshi; Y Maehara; K Sugimachi
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113

View more
  2 in total

1.  Adenocarcinoma of esophagogastric junction.

Authors:  Jing-Yu Deng; Han Liang
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

2.  Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.

Authors:  H Luo; Y Y Cui; J G Zhang; Y N Sun; X L Zheng; C L Yang; K Ye; H Ge
Journal:  Clin Transl Oncol       Date:  2017-11-15       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.